Virtus ETF Advisers’s NextCure NXTC Stock Holding History

Virtus ETF Advisers’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,035	Closed	-$244K	–	402
2021 Q1	$244K	Buy	2,035 +36	+2%	+$5.21K	0.1%	294
2020 Q4	$261K	Buy	1,999 +917	+85%	+$118K	0.11%	297
2020 Q3	$114K	Sell	1,082 -147	-12%	-$18.1K	0.06%	315
2020 Q2	$316K	Buy	1,229 +651	+113%	+$248K	0.15%	294
2020 Q1	$257K	Sell	578 -83	-13%	-$44.3K	0.11%	246
2019 Q4	$447K	Buy	+661	New	+$332K	0.07%	221

Other funds holding NXTC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CPX

Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtus ETF Advisers's NXTC Position: Q2 2021 in Review

Virtus ETF Advisers sold out of NextCure (NXTC) in Q2 2021, closing a stake of 2,035 shares — an estimated $244K sold.

Virtus ETF Advisers first reported a position in NXTC in Q4 2019 and held it in 6 quarters. The position peaked at $447K in Q4 2019. 78 funds tracked by Wall St. Rank hold NXTC as of Q2 2021.

Virtus ETF Advisers reported no remaining NextCure position as of Q2 2021 after selling out during the quarter.
Virtus ETF Advisers sold 2,035 NextCure shares in Q2 2021, an estimated $244K.
Virtus ETF Advisers first reported a position in NextCure in Q4 2019 and held it in 6 quarters.
Virtus ETF Advisers's NextCure position peaked at $447K in Q4 2019.
78 funds tracked by Wall St. Rank held NextCure as of Q2 2021.

Based on Virtus ETF Advisers's 13F filing for Q2 2021, filed 10 Aug 2021.